Anti-influenza virus activity of a salcomine derivative mediated by inhibition of viral RNA synthesis

Viral Infections, Non-HIV

H3N2 Influenza Viruses in Humans: Viral Mechanisms, Evolution, and Evaluation

Hum Vaccin Immunother.

Allen JD, Ross TM

doi: 10.1080/

Viral Infections, Non-HIV

Detection of Influenza A(H3N2) Virus RNA in Donated Blood

Emerg Infect Dis.

Dos Santos Bezerra R, de Melo Jorge DM, Castro ÍA, Moretto EL, Scalon de Oliveira L, Ubiali EMA, Covas DT, Arruda E, Kashima S, Slavov SN

doi: 10.3201/eid2607.200549.

Viral Infections, Non-HIV

The role of extracellular histones in influenza virus pathogenesis

Am J Pathol.

Ashar HK, Mueller NC, Rudd JM, Snider TA, Achanta M, Prasanthi M, Pulavendran S, Thomas PG, Akhilesh R, Malayer JR, Ritchey JW, Rajasekhar R, Chow VT, Esmon CT, Teluguakula N

doi: 10.1016/j.ajpath.2017.09.014.

HIV / AIDSViral Infections, Non-HIV

Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses

Antiviral Res.

Hu Y, Zhang J, Musharrafieh RG, Ma C, Hau R, Wang J

doi: 10.1016/

Viral Infections, Non-HIV

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

Lancet Respir Med.

Davey RT Jr, Fernández-Cruz E, Markowitz N, Pett S, Babiker AG, Wentworth D, Khurana S, Engen N, Gordin F, Jain MK, Kan V, Polizzotto MN, Riska P, Ruxrungtham K, Temesgen Z, Lundgren J, Beigel JH, Lane HC, Neaton JD, INSIGHT FLU-IVIG Study Group.

doi: 10.1016/S2213-2600(19)30253-X.

Viral Infections, Non-HIV

Pharmacological analysis of transmission activation of two aphid-vectored plant viruses, turnip mosaic virus and cauliflower mosaic virus

Sci Rep.

Berthelot E, Macia JL, Martinière A, Morisset A, Gallet R, Blanc S, Khelifa M, Drucker M

doi: 10.1038/s41598-

Viral Infections, Non-HIV

CHARACTERIZATION OF INFLUENZA B VIRUS VARIANTS WITH REDUCED NEURAMINIDASE INHIBITOR SUSCEPTIBILITY

Antimicrob Agents Chemother.

Farrukee R, Zarebski AE, McCaw JM, Bloom JD, Reading PC, Hurt AC

doi: 10.1128/AAC.01081-18.

Further Publications Infectiology

Relative Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-Derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-Related Medical Encounters During the 2018-2019 Influenza Season in the United States

Clin Infect Dis

Boikos C, Fischer L, O'Brien D, Vasey J, Sylvester GC, Mansi JA

doi: 10.1093/cid/ciaa1944

Viral Infections, Non-HIV

A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults

Infection.

Loebermann M, Fritzsche C, Geerdes-Fenge H, Heijnen E, Kirby D, Reisinger EC

doi: 10.1007/s15010-018-1233-2.

Related content

H3N2 Influenza Viruses in Humans: Viral Mechanisms, Evolution, and Evaluation

Detection of Influenza A(H3N2) Virus RNA in Donated Blood

The role of extracellular histones in influenza virus pathogenesis

Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

Pharmacological analysis of transmission activation of two aphid-vectored plant viruses, turnip mosaic virus and cauliflower mosaic virus

CHARACTERIZATION OF INFLUENZA B VIRUS VARIANTS WITH REDUCED NEURAMINIDASE INHIBITOR SUSCEPTIBILITY

Relative Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-Derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-Related Medical Encounters During the 2018-2019 Influenza Season in the United States

A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults